Dr. Chaturvedi has developed a heuristic-logic-based framework—The theory of Sphenome—which postulates that causality and not randomness is the defining predictor of probabilistic generalizations, whether in nature or a laboratory. As our understanding of the predicate interactions increases, we can affect desired results in nature and a laboratory. Therefore, the Theory of Sphenome is a non-string methodology of analyzing many Hamiltonians, from the quantum to the galactic scales. He postulates that atto-scale, ubiquitously present fundamental particles—Spheons— are present in most known forms of energy and matter. Dr. Chaturvedi has iteratively validated his postulated theoretical constructs with experimental data over a thirty-year timespan. His research has led to the creation of the Sphenome Heuristics Framework (SHF). Dr. Chaturvedi has used a proprietary form of in-silico modeling to generate Impact Simulations and built tools for machine learning and a form of intelligence in computing—Sphenome AI. The theory of Sphenome, Sphenimes, and Sphenomenal transforms further posits that a plurality of classes of the naturally present Spheons may be a novel construct to understand phenomena. Moreover, by purposefully modulating Spheons, as validated in silico, we may achieve those results considered impossible in the prevailing theories in the sciences.

SHF postulates that the core of a planet has a less than significant role in the origin and mechanism of gravitational force experienced on the planet. This is contrary to the prevalent theory of gravity that gravitational forces which exist between planets are planetary-mass dependent, or that there is a universality of the "gravitational constant". We postulate that Spheon vortices and currents are responsible for the manifestation of gravitational force-effect in a planet. Knowledge of and the potential modulation of these vortices has the potential to provide sustained artificial gravity to promote safe prolonged human inhabitation in space, or seeding atmospheric conditions on planets in general or Mars as a particular example. The proposed Auvura stations in near earth space, novel active-launch platforms rely on several SHF constructs, including those on spheon-modulated gravity generation. The Auvura program has the potential to establish bases on Mars and seeding viable water bodies with reliable atmospheric conditions are based on terraforming-related SHF postulates, including the framework of generating gravitational forces on a larger scale.

SHF postulates on the origin life and the genomic basis of evolution of human beings on Earth may be incorrect. As a result, the understanding that evolutionary origin of life on the planet Earth began about 4 billion years ago or that humans evolved from apes is not likely. As a use case, SHF further builds on a construct of genomic evolution of a species to optimize performance and increase healthier life-spans. Effective treatments and interventions which have the potential to result in “cure” of major diseases or certain cancers, otherwise considered incurable, in theory, are possible with targeted spheon-based genomic-expression modulation.

The postulates of the functional gene-expression in a living cell define a ubiquitous and nuclear and intracellular presence. The in vivo structure of the expressed DNA is not helical as widely believed. The bindings and interactions of bases and their protein expression is subject to modulation and changes with a variety of factors inside the nucleus, cellular physiologic and biochemical state, and indeed the entire body, at large, and further that this manifests in real time and is ever present. The ability to modulate and dynamically influence genomic expression through natural pathways has the potential for treatments and reversals of otherwise incurable and chronic diseases. Predictable spheon modulations represent a potential to introduce a new class of pharmaceutical interventions in medicine.

Today, we are creating a futuristic ICU with alternatives to the extensively used high-voltage defibrillators. Our proposed bioelectricity modulators have the potential to yield better five-year survivals. The prevalent theory on clinical death is defined primarily by a pulse-less heart and the known fact that brain cells cannot live beyond a few minutes without oxygen. SHF postulates that physicians equipped with an advanced bioelectricity modulator will be able to resuscitate patients for up to twenty-four hours after clinical death. Human death occurs in six primary stages of different bioelectricity-carrying spheons at varying rates in cells found in the body— 1. Type V in blood - [minutes]2. Type M in specific tissues - [in hours]. 3. Type N in specific brain and spinal cord tissue - [hours],4. Type O in specific bone tissue - [years],5. Type T in specific tooth tissue -[decades], 6. Type H in specific hair tissue - [100+ years].—Our theoretical research on harnessing v-class spheons and transfusing them into a clinically dead patient may receive approval in our proposed SphReI-HxVaccine trial.

Multiple classes of naturally occurring, fundamental, sub-atomic, atto scale particles are principal mediators of ubiquitous interactions between inorganic and organic energy and matter, inside a life form and outside. Novagenome—a platform of Moolex is engaged in developing the concept of instituting genomic repair of livestock and crops to reverse degradation in the quality of produce and agriculture production.

The modulation of Spheons in nature—on earth and in space and the ability to create cascades of effects in naturally occurring spheons can unleash higher bandwidth utilization in telecommunications and utilize improved antennae to study solar radiation and fluxes in Earth's upper atmosphere. The NetGrid concept in data networks and telecom has the potential to avoid many limitations in radiofrequency-based transforms that power the internet and satellite communication today.

We have developed the concept of enhancing natural mitochondrial DNA expression in-vivo. Our first pilots pending submission to the FDA for Emergency Use Authorization involve using a modification of human plasma into a patient. Our simulations predict substantial immunity enhancement within twenty-four hours. Today's mRNA-based vaccines, or those based on viral-protein--antigenic triggers, take up to four weeks.